Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

(2011) Hajime Maeda et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Polyunsaturated Fatty Acid Levels of Serum and Red Blood Cells in Apparently Healthy Japanese Subjects Living in an Urban Area

(2011) Naotake Yanagisawa et al.   Journal of Atherosclerosis and Thrombosis

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

(2010) et al.   Journal of Diabetes Investigation

GIP and GLP-1, the two incretin hormones: Similarities and differences

(2010) Yutaka Seino et al.   Journal of Diabetes Investigation

Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study

(2009) Debora Williams-Herman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Serum N-3 Polyunsaturated Fatty Acid Levels Correlate With the Extent of Coronary Plaques and Calcifications in Patients With Acute Myocardial Infarction

(2008) Masayuki Ueeda et al.   CIRCULATION JOURNAL

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

(2008) Kenji Nonaka et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Usefulness of colon targeted DHA and EPA as novel diabetes medications that promote intrinsic GLP-1 secretion

(2008) Mariko Morishita et al.   JOURNAL OF CONTROLLED RELEASE

Marine-Derived n-3 Fatty Acids and Atherosclerosis in Japanese, Japanese-American, and White Men

(2008) Akira Sekikawa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY